![Mark Vickery Mark Vickery](https://staticx.zacks.com/images/mugshots/mark_vickery/mark_vickery-8.png)
Top Research Reports for UnitedHealth, Walmart & AT&T
![](https://staticx.zacks.com/images/zt/ztNow_icon2.png)
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tuesday, June 19, 2018
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Walmart (WMT) and AT&T (T). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
UnitedHealth's shares have outperformed the Zacks Medical Insurance industry year to date (up +15.6% vs. +13.3%). The Zacks analyst thinks the company's robust Government business and continued strong performance at Optum are driving long-term growth. Its international business and strong capital position driving business investment are the other positives.
The company has been witnessing an increase in membership over the past many years. It again lifted its 2018 earnings guidance, buoying optimism among investors in the stock. The company has witnessed its 2018 estimate increase by 1.2% to $12.62 over the past 90 days.
However, membership loss in its fee-based commercial as well as Brazilian businesses will contract the overall membership growth for UnitedHealth Group. Additionally, higher medical care ratio raises concern.
(You can read the full research report on UnitedHealth here >>>).
Shares of Walmart have lost -16% in the last six months, underperforming the Zacks Supermarkets industry's -14.5% decline in the same time period. The Zacks analyst thinks Walmart is poised to gain from its strong e-commerce initiatives, particularly expansion of online grocery delivery. This, along with efforts to drive brick-and-mortar sales should help the company maintain its sturdy U.S. comps trend.
Walmart is also undertaking efforts to improve the performance of its International unit, by shifting focus from underperforming regions to profitable countries like India and China. To this end, the company’s recent investment in Flipkart is however expected to dent the bottom line in the near term.
Further, investments related to the e-commerce initiatives and a compelling pricing strategy have been hurting Walmart’s gross margin. Nonetheless, the Flipkart deal bodes well for the long term, which along with focus on buyouts, alliances and improved delivery services should help Walmart stand firm against Amazon.
(You can read the full research report on Walmart here >>>).
AT&T’s shares have decreased -11.4% in the last three months, underperforming the Zacks Wireless National industry's fall of -4.3%. AT&T is gearing up to launch the first standards-based mobile 5G services to consumers in multiple U.S. markets by the end of 2018.
The Zacks analyst thinks the company is likely to benefit from its long-pending merger with Time Warner. Given the scale of both AT&T and Times Warner, the merger is likely to reshape the industry dynamics, creating a media behemoth. The deal will allow the power packed combination of AT&T’s data and Time Warner's content.
However, AT&T’s profitability has been hurt with spectrum crunch in a saturated wireless market. In addition, the company’s wireline division is struggling with persistent losses in access lines due to competitive pressure from voice-over-Internet protocol service providers and aggressive triple-play offerings by cable firms. These are weighing on AT&T’s revenues and margins.
(You can read the full research report on AT&T here >>>).
Other noteworthy reports we are featuring today include NIKE (NKE), Thermo Fisher (TMO) and Anthem (ANTM).
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Get the latest research report on T - FREE
Get the latest research report on NKE - FREE
Get the latest research report on UNH - FREE
Get the latest research report on WMT - FREE
Get the latest research report on TMO - FREE